Dementia Today.net

Site updated at Tuesday, 21 October 2014

Living with Dementia

Creutzfeldt-Jakob Disease Signs and Symptoms

  • - Creutzfeldt-Jacob Dementia
  • Jun 25, 2011
  • Comments
  • Viewed: 3404
Tags: | cjd | creutzfeldt-jakob disease | depression | disorientation |

Diagnosis

CJD is diagnosed by a clinical neurological exam and electroencephalography (EEG), which shows characteristic spikes called triphasic sharp waves. Magnetic resonance imaging (MRI) or computed tomography scans (CT) should be done to exclude other forms of dementia, and in CJD typically shows atrophy or loss of brain tissue. Lumbar puncture, or spinal tap, may be done to rule out other causes of dementia (as cell count, chemical analysis, and other routine tests are normal in CJD) and to identify elevated levels of marker proteins known as 14-3-3. Another marker, neuron-specific enolase, may also be increased in CJD. CJD is conclusively diagnosed after death by brain autopsy. Scientists are investigating whether testing lymphatic tissue such as the tonsil may be an early tool in vCJD diagnosis. Additionally, recent studies have suggested that other blood tests may be useful as well.

Treatment

There is no cure for CJD, and no treatment that slows the progression of the disease. Drug therapy and nursing care are aimed at minimizing psychiatric symptoms and increasing patient comfort. However, the rapid progression of CJD frustrates most attempts at treatment, since decreasing cognitive function and more prominent behavioral symptoms develop so quickly. Despite the generally grim prognosis, a few CJD patients progress more slowly and live longer than the average; for these patients, treatment will be more satisfactory. Scientists are investigating whether some medicines that can “break” the abnormal protein form may be useful and whether a vaccine could help.

Prognosis

Creutzfeldt-Jakob disease is invariably fatal, with death following symptom onset by an average of eight months. About 5% of patients live longer than two years. Death from vCJD has averaged approximately 12 months after onset.

Prevention

There is no known way to prevent sporadic CJD, by far the most common type. Not everyone who inherits the gene mutation for familial CJD will develop the disease, but at present, there is no known way to predict who will and who won’t succumb. The incidence of iatrogenic CJD has fallen with recognition of its sources, the development of better screening techniques for infected tissue, and the use of sterilization techniques for surgical instruments that inactivate prion proteins.

Strategies for prevention of vCJD are a controversial matter, as they involve a significant sector of the agricultural industry and a central feature of the diet in many countries. The infectious potential of contaminated meat is unknown, because the ability to detect prions within meat is limited. Surveillance of North American herds strongly suggests there is no BSE here, and strict regulations on imports of European livestock make future outbreaks highly unlikely. Therefore, avoidance of all meat originating in North America, simply on grounds of BSE risk, is a personal choice unsupported by current data. The ban on the export of British beef continues in countries of the European Union, although some herds in these countries have developed low levels of infection as well.

 

###
By Larry I. Lutwick MDThe Gale Group Inc.

Page 3

1 2 3



Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]




Comment
Your details

* Required field


Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

Going Home (A short film on Dementia)

resveratrol1 - dopamine deficiency1 - alzheimer's disease risk1 - wernicke's disease10 - caffeine1 - changes in mood1 - beta secretase1 - 1215-lipoxygenase1 - thiamin deficiency1 - dementia119 - cognitive abilities1 - cholesterol1 - blood thinning medications1 - sinus issues1 - quantitative structural neuroimaging1 - obstructive lung disease1 - stupidity2 - mild traumatic brain injury1 - substantia nigra6 - risk factors for dementia1 - protein amyloid beta1 - signs of alzheimer's1 - sleep loss1 - confabulatory euphoria1 - aripiprazole1 - amyloid beta7 - csf1 - developing alzheimer's disease1 - hyperlipidemia1 - neuroanatomical changes1 -